CompanyGANXNasdaqBethesda, MD

Gain Therapeutics, Inc.

Gain Therapeutics is a clinical-stage biotechnology company developing allosteric small molecule therapies.

SEC EDGAR ClinicalTrials.gov russopartnersllc.com

8-KOct 1Latest SEC filing

Sep 28Latest story

September 2026

Gain Therapeutics CFO to resign, CEO to serve as interim finance chief

Sep 28PeopleGain Therapeutics, Inc.

August 2026

Gain Therapeutics gets FDA IND clearance for rexaceract, targets Phase 2 start in Q3 2026

Aug 11Quarterly updateGain Therapeutics, Inc.